InfuSystem reports Q4 EPS 4c, consensus 6c

Reports Q4 revenue $33.8M, consensus $34.9M. Richard DiIorio, CEO of InfuSystem (INFU), said, “Our financial results in 2024 came in consistent with our plan. At the start of the year, we announced that after a strong growth year in 2023, our priority in 2024 would be continuous process improvements that would increase our operating margins and long-term profit potential. We can report that we delivered on that priority. Compared to the prior year gross margins improved by 2% to 52.2%, operating income increased by 69% to $6.9 million, and Adjusted EBITDA rose 13% to $25.3 million. The Adjusted EBITDA margin percentage was 18.8% representing a 1.0% improvement over 2023, in line with our guidance even with the inclusion of $735 thousand of technology systems upgrade costs that were not included in our original forecast for the year.”